Table 1 Clinical and pathological characteristics of patients.
Characteristics | Mean ± Standard deviation/Percentage |
|---|---|
Age | 52.7 ± 11.9 years |
Initial tumour size | 5.5 ± 2.7 cm |
Histology | |
Invasive ductal carcinoma: 93.4% | |
Invasive lobular carcinoma: 4.1% | |
Invasive metaplastic carcinoma: 2.5% | |
Tumour grade | |
Grade I: 1.4% | |
Grade II: 50.9% | |
Grade III: 47.7% | |
Molecular features | |
ER + : 62.3% | |
PR + : 59.7% | |
HER2 + : 30.1% | |
Triple negative: 25% | |
ER + /PR + / HER2 + : 16.7% | |
ER + /PR + /HER2−: 41.7% | |
ER−/PR−/HER2 + : 8.3% | |
Residual tumour size | 3.2 ± 4.3 cm |
Response | |
Responding patients: 77.8% | |
Non-responding patients: 22.2% | |
